BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suda K. Recent Advances in Cancer Immunotherapy. Biomolecules 2021;11:335. [PMID: 33672298 DOI: 10.3390/biom11020335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Xiong J, Sun X, Gao H. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. Acta Pharm Sin B 2022;12:4327-47. [PMID: 36561994 DOI: 10.1016/j.apsb.2022.11.001] [Reference Citation Analysis]
2 Lauk K, Peters M, Velthaus J, Nürnberg S, Ueckert F. Use of Process Modelling for Optimization of Molecular Tumor Boards. Applied Sciences 2022;12:3485. [DOI: 10.3390/app12073485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fan X, He C. Comprehensive analysis of the immunogenomic landscape and clinical features in cervical cancer.. [DOI: 10.1101/2021.08.24.21262578] [Reference Citation Analysis]